Detalhe da pesquisa
1.
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
Cell
; 176(3): 564-580.e19, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580964
2.
Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.
Cell
; 161(7): 1539-1552, 2015 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26091037
3.
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer.
Cell
; 158(3): 579-92, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25083869
4.
Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor ß signaling.
Cell
; 157(2): 382-394, 2014 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24725405
5.
Non-cell-autonomous tumor suppression by p53.
Cell
; 153(2): 449-60, 2013 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23562644
6.
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer.
Cell
; 165(6): 1546-1547, 2016 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27259155
7.
Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells.
Gastroenterology
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636680
8.
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets.
Proc Natl Acad Sci U S A
; 119(17): e2110557119, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442775
9.
Etiology-independent activation of the LTß-LTßR-RELB axis drives aggressiveness and predicts poor prognosis in HCC.
Hepatology
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916976
10.
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer.
Gut
; 71(8): 1613-1628, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34509979
11.
Multiplexed orthogonal genome editing and transcriptional activation by Cas12a.
Nat Methods
; 16(1): 51-54, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559432
12.
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma.
Genes Dev
; 28(16): 1800-14, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25128497
13.
DNAJB1-PRKACA fusion kinase interacts with ß-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.
Proc Natl Acad Sci U S A
; 114(50): 13076-13084, 2017 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29162699
14.
Quantitative self-assembly prediction yields targeted nanomedicines.
Nat Mater
; 17(4): 361-368, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29403054
15.
Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness.
Hepatology
; 67(5): 1842-1856, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29152770
16.
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.
Gastroenterology
; 144(7): 1530-1542.e12, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23419361
17.
Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors.
Eur J Immunol
; 42(12): 3369-80, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23001948
18.
Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.
Gut
; 61(8): 1209-18, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22287599
19.
MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer.
Elife
; 122023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37261974
20.
Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
J Hepatol
; 55(5): 1049-57, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21356256